Athanasios Kotsakis
Overview
Explore the profile of Athanasios Kotsakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thanou E, Lontra D, Balgouranidou I, Efthimiadou E, Delipetrou A, Tsaroucha E, et al.
Biomolecules
. 2025 Jan;
14(12.
PMID: 39766220
Liquid biopsy enables real-time monitoring of tumor development and response to therapy through the analysis of CTCs and ctDNA. NALCN is a sodium leak channel that is frequently involved in...
2.
Tsilingiri K, Chalari A, Christopoulou G, Voutsina A, Constantoulakis P, Potaris K, et al.
NPJ Precis Oncol
. 2024 Dec;
8(1):291.
PMID: 39725687
PARP inhibitors (PARPi) have shown efficacy in tumours harbouring mutations in homologous recombination repair (HRR) genes. Somatic HRR mutations have been described in patients with Non-Small Cell Lung Cancer (NSCLC),...
3.
Fiste O, Mavrothalassitis E, Kokkalis A, Anagnostakis M, Gomatou G, Kontogiannis A, et al.
Clin Transl Oncol
. 2024 Dec;
PMID: 39668275
Background: Neoadjuvant systemic therapy (NAT) represents an attractive option for improved outcomes of early-stage breast cancer (BC) patients, as it can significantly reduce tumor burden thus permitting breast-conserving resections. Equally...
4.
Bafiti V, Thanou E, Ouzounis S, Kotsakis A, Georgoulias V, Lianidou E, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594687
Background And Objective: Lung cancer, the second most prevalent cancer globally, poses significant challenges in early detection and prognostic assessment. Despite advancements in targeted therapies and immunotherapy, the timely identification...
5.
Papakonstantinou D, Roumeliotou A, Pantazaka E, Shaukat A, Christopoulou A, Koutras A, et al.
Mol Oncol
. 2024 Nov;
PMID: 39575761
The increased metastatic ability of small-cell lung cancer (SCLC) necessitates the identification of new prognostic biomarkers for clinical evaluation during the disease course. Our previous research highlighted the clinical relevance...
6.
Ntzifa A, Marras T, Kallergi G, Kotsakis A, Georgoulias V, Lianidou E
Front Oncol
. 2024 Nov;
14:1435537.
PMID: 39497713
Background: The heterogeneous and complex genetic landscape of NSCLC impacts the clinical outcomes of patients who will eventually develop resistance to osimertinib. Liquid biopsy (LB) analysis as a minimally invasive...
7.
Tsokani A, Stefanouli V, Adriaenssens N, Kotsakis A, Kapreli E, Strimpakos N
Int J Environ Health Res
. 2024 Aug;
:1-15.
PMID: 39166712
Green exercise, defined as physical activity in natural settings, shows promise for enhancing exercise participation and improving health. This systematic review aimed to assess the effectiveness of green exercise in...
8.
Xagara A, Goulielmaki M, Fortis S, Kokkalis A, Chantzara E, Christodoulopoulos G, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001455
T-cell-mediated anti-tumoral responses may have significant clinical relevance as a biomarker for response to immunotherapy. The value of peripheral blood pre-existing tumor antigen-specific T cells (PreI) as a predictive immunotherapy...
9.
Roumeliotou A, Strati A, Chamchougia F, Xagara A, Tserpeli V, Smilkou S, et al.
Cells
. 2024 May;
13(9.
PMID: 38727318
CXCR4, JUNB and PD-L1 are implicated in cancer progression and metastasis. The current study investigated these biomarkers in CTCs isolated from metastatic prostate cancer (mPCa) patients at the RNA and...
10.
Vasilis N, Kyriakides A, Vasilopoulos G, Chatzitimotheou M, Gonidakis G, Kotsakis A, et al.
Sports (Basel)
. 2024 Apr;
12(4).
PMID: 38668569
This cross-sectional epidemiological study aimed to evaluate the prevalence of injuries among young archers engaged in high-intensity training during the European Youth Championship. A total of 200 participants (104 males/96...